We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+22.3%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$455M
AUM Growth
+$90.7M
Cap. Flow
+$33.6M
Cap. Flow %
7.38%
Top 10 Hldgs %
56.91%
Holding
55
New
3
Increased
34
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$15.3M
2
SHPG
Shire pic
SHPG
+$13.8M
3
NEO icon
NeoGenomics
NEO
+$7.39M
4
NVTR
Nuvectra Corporation Common Stock
NVTR
+$4.2M
5
HBIO icon
Harvard Bioscience
HBIO
+$3.6M

Top Sells

Rank Stock Value
1
ENTL
Entellus Medical, Inc. Common Stock
ENTL
+$16.4M
2
NKTR icon
Nektar Therapeutics
NKTR
+$4.44M
3
BLUE
bluebird bio
BLUE
+$2.44M
4
QDEL icon
QuidelOrtho
QDEL
+$2.04M
5
CDXS icon
Codexis
CDXS
+$1.63M

Sector Composition

Rank Sector Weight
1 Healthcare 84.88%
2 Communication Services 4.24%
3 Energy 0.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXTM
26
DELISTED
NxStage Medical Inc.
NXTM
$4.81M 1.06%
193,339
+669
+0.3% +$16.3K
VCYT icon
27
Veracyte
VCYT
$3.7B
$4.72M 1.04%
849,566
+58,229
+7% +$360K
LHCG
28
DELISTED
LHC Group LLC
LHCG
$4.43M 0.97%
71,999
+3,192
+5% +$201K
BLUE
29
DELISTED
bluebird bio
BLUE
$4.34M 0.95%
1,962
-959
-33% -$2.44M
QDEL icon
30
QuidelOrtho
QDEL
$1.14B
$3.94M 0.87%
76,068
-43,833
-37% -$2.04M
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$121B
$3.82M 0.84%
23,429
+372
+2% +$60.8K
TLGT
32
DELISTED
Teligent, Inc
TLGT
$3.7M 0.81%
110,082
-40,231
-27% -$1.28M
STRM
33
DELISTED
Streamline Health Solutions
STRM
$3.49M 0.77%
126,512
+34,842
+38% +$902K
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.58M 0.57%
31,850
+637
+2% +$54.7K
IBB icon
35
iShares Biotechnology ETF
IBB
$9.34B
$2.27M 0.5%
21,291
– –
IRIX icon
36
IRIDEX
IRIX
$14.3M
$2.22M 0.49%
387,687
+69,888
+22% +$484K
XLVS
37
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
$1.93M 0.42%
17,285
– –
IONS icon
38
Ionis Pharmaceuticals
IONS
$8.6B
$1.87M 0.41%
42,464
+617
+1% +$31.3K
ALKS icon
39
Alkermes
ALKS
$8.22B
$1.75M 0.38%
30,211
+678
+2% +$39.7K
KIDS icon
40
OrthoPediatrics
KIDS
$519M
$1.75M 0.38%
+116,185
New +$2.06M
LMAT icon
41
LeMaitre Vascular
LMAT
$2.32B
$1.7M 0.37%
46,910
+791
+2% +$27.4K
XLV icon
42
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.49M 0.33%
18,241
– –
IHI icon
43
iShares US Medical Devices ETF
IHI
$3.13B
$1.4M 0.31%
45,480
– –
ENZ
44
DELISTED
Enzo Biochem, Inc.
ENZ
$1.38M 0.3%
251,002
+13,948
+6% +$98.3K
CELG
45
DELISTED
Celgene Corp
CELG
$1.24M 0.27%
13,852
+340
+3% +$32.6K
ABBV icon
46
AbbVie
ABBV
$443B
$394K 0.09%
4,159
– –
DYNT
47
DELISTED
Dynatronics Corp
DYNT
$321K 0.07%
21,397
+521
+2% +$7.53K
PFE icon
48
Pfizer
PFE
$143B
$304K 0.07%
9,020
– –
NVS icon
49
Novartis
NVS
$297B
$289K 0.06%
3,986
– –
JNJ icon
50
Johnson & Johnson
JNJ
$618B
$280K 0.06%
2,183
– –
1
2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, First Light Asset Management held 55 positions worth $455M, up 25% from $365M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

First Light Asset Management deployed $33.6M of net new capital in Q1 2018, opening 3 new positions and adding to 34 existing holdings. Its largest new stake was Tandem Diabetes Care: 4,734,238 shares worth $23.5M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 84% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Nektar Therapeutics, an estimated $4.44M trimmed.

  • First Light Asset Management's largest Q1 2018 buy was Tandem Diabetes Care: 4,734,238 shares worth $23.5M.
  • First Light Asset Management added most to Shire pic in Q1 2018, an estimated $13.8M increase.
  • First Light Asset Management's biggest Q1 2018 reduction was Nektar Therapeutics, cutting an estimated $4.44M.
  • First Light Asset Management fully exited Entellus Medical, Inc. Common Stock in Q1 2018, selling an estimated $16.4M.
  • First Light Asset Management's ten largest holdings make up 57% of its $455M portfolio in Q1 2018.
  • First Light Asset Management opened 3 new positions and closed 3 in Q1 2018.
  • First Light Asset Management's portfolio value rose 25% quarter-over-quarter to $455M.

Based on First Light Asset Management's 13F filing for Q1 2018, filed 15 May 2018.